eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

GlaxoSmithKline UK
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 01/06/2010
PIL Avandamet Film-Coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/06/2010 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 14/09/2009 and displayed until 01/06/2010
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to Further Information section
Updated on 12/09/2008 and displayed until 14/09/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 22/06/2007 and displayed until 12/09/2008
Reasons for adding or updating:
  • Manufacturer has withdrawn from eMC
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 06/03/2007 and displayed until 22/06/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 18/12/2006 and displayed until 06/03/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 29/08/2006 and displayed until 18/12/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 29/03/2006 and displayed until 29/08/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to warnings or special precautions for use
  • Change to, or new, use for medicine
Updated on 23/11/2005 and displayed until 29/03/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 03/03/2005 and displayed until 23/11/2005
Reasons for adding or updating:
  • Change to date of revision
  • Change to how to administer the medicine
  • Change to drug interactions
Updated on 10/08/2004 and displayed until 03/03/2005
Reasons for adding or updating:
  • Change to storage instructions
  • Change to date of revision
Updated on 06/11/2003 and displayed until 10/08/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  rosiglitazone
  metformin hydrochloride